Skip to content

The effect of periodontal treatment on blood parameters

The effect of chronic periodontitis treatment on blood parameters

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151013024509N3
Enrollment
54
Registered
2018-02-09
Start date
2018-02-14
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic periodontitis. Chronic periodontitis

Interventions

Intervention 1: Control group: 18 people with healthy periodontium, at the beginning of the study, complete periodontal examinations and taking blood samples and sent to the laboratory, 6 weeks later

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
25 Years to 50 Years

Inclusion criteria

Inclusion criteria: Male patients ( 25-50 years ) With lack of systemic diseases such as: diabetes, kidney disease, cancer Fungal and respiratory diseases No history of hospitalization No history of receiving or donating blood No periodontal treatment in the last three months Non- use of cigarettes, alcohol and tobacco Serum ferritin levels greater than 50 ng/ml Do not use the following medications: warfarin, anti-coagulants, lithium, aspirin Corticosteroid drugs Heparin, phenytoin Anti-hypertensive drugs Non steroid anti-inflamatory drugs Antibiotics Antiarrhythmic drugs Drugs used in the treatment of kidney patients

Exclusion criteria

Exclusion criteria: A patient who doesn't attend for giving blood sample after 6 weeks when periodontal treatment was not conduced completely for any specefic reason

Design outcomes

Primary

MeasureTime frame
Moderate to severe chronic periodontitis. Timepoint: At the beginning of the study (before the intervention) and 6 weeks after the beginning of the study. Method of measurement: All patients under periodontal examination, including the recording of bleeding on probing (BOP), periodontal pocket depth ( PPD) and clinical attachment loss (CAL) indices.

Secondary

MeasureTime frame
Blood parameters. Timepoint: At the beginning of the study (before the intervention) and after 6 weeks. Method of measurement: Taking blood samples of patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahimeh Rashidi Maybodi

Yazd University of Medical Sciences

F-rashidi63@ssu.ac.ir+98 35 3625 1222

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026